Stay updated with breaking news from Nasdaq Slno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) major shareholder Vivo Opportunity, Llc sold 750,000 shares of the firm’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $47.80, for a total transaction of $35,850,000.00. Following the completion of the transaction, the insider now directly owns 7,668,093 […]
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage...
First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned...
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 18,980 shares of the firm’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $784,633.20. Following the sale, the chief executive officer now owns 152,790 shares in the company, […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) insider Kristen Yen sold 2,218 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $41.34, for a total transaction of $91,692.12. Following the transaction, the insider now directly owns 23,422 shares in the company, valued at […]